TrialInternational journal of radiation oncology, biology, physics2018

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment.

Xiao-Tang Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.